Skip to main content

InvestorNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) to Obtain Key Consumer Research through Store-Level Initiatives

TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) announced that it is beginning to conduct consumer research at three north-central Ohio tobacco outlets. The company acquired the outlets as part of its recent acquisition of ADCO, a major Ohio tobacco distributor. TAAT intends to use the research it obtains through these initiatives in its distribution efforts across Ohio as well as nationwide. According to the announcement, the three tobacco outlets carry a standard range of popular tobacco cigarettes as well as all three varieties of TAAT(R), the company’s flagship nicotine-free, tobacco-free product. The company intends to implement store-level initiatives to obtain feedback from adult smokers in various situations, obtaining a level of information and detail that is unprecedented in the tobacco or consumer packaged goods (“CPG”) categories. “Most brands have very little visibility into how their product performs at the point of sale, especially in relation to products from competitors,” said TAAT founder Joe Deighan in the press release. “Although some insights can be obtained at a macro level through metrics such as scan records and certain quantitative data points, there is no substitute for being able to observe your target customers firsthand as they go about contemplating or making a purchase. Now that TAAT owns three tobacco outlets in Ohio, we are able to roll out tailored in-store research initiatives to help us better understand how adult smokers react when they are offered TAAT. By actively comprehending what factors might contribute to any potential objections or hesitation to trying TAAT, we are able to fine-tune our retailing strategies to overcome some of those pain points with an objective of bolstering our conversion rates. We are very excited about launching these in-store research programs, which I believe could be very impactful for commercializing TAAT as a better and nicotine-free alternative to tobacco cigarettes.”

To view the full press release, visit https://ibn.fm/JfTnY

About TAAT Global Alternatives Inc.

TAAT develops, manufactures and distributes alternative products in categories to include tobacco, hemp, kratom and other emerging segments of the CPG industry. Its flagship product is a nicotine-free, tobacco-free cigarette with a patent-pending base material formulation, sold in more than 2,700 stores in the United States. TAAT’s facilities include a manufacturing plant in Nevada as well as a distribution center and multiple convenience stores in Ohio; the company reported more than C$80 million in overall net revenue in 2021. For more information about the company, please visit www.TAATGlobal.com.  

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.